.
.
may 17, 2018
.
"future placement of tooth implants if needed will be much easier," he said.
.
you have successfully subscribed to the breaking news email.
.
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.